(PharmaNewsWire.Com, December 27, 2017 ) Kidney Cancer is defined as malicious development of cells in certain specific tissues of kidney, which h forms a tumor. Kidney cancer caused 4,421 deaths in UK in 2014, while it is responsible for 3% of human death all over the world. Renal cell carcinoma is the most common kidney cancer, covering 85% of kidney cancer cases.
High-intensity focused ultrasound (HIFU) is a new method that is currently being tested for use in kidney cancer. It includes indicating extremely focused ultrasound beams from outside the body to destroy the tumor. With new technologies like HIFU and other drugs being introduced, European kidney cancer and diagnostics and Therapeutics market is bound to flourish in next few years.
The report provides a detailed analysis of drivers and constraints that controls growth of the market. Some of the drivers are: Increasing consumption of alcohol and smoking Advanced Healthcare. Prevalence of kidney cancer.
For deep understanding Kidney Cancer Diagnostics and Therapeutics Market is segmented by type and tests. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
The market for Kidney Cancer Diagnostics and Therapeutics, on the basis of Type is segmented into Transitional Cell Cancer, Renal cell carcinoma, renal sarcoma, and others. On the basis of Tests, the Kidney Cancer Diagnostics and Therapeutics market is segmented into Biopsy, CT scan, Cystoscopy, Intravenous pyelogram, Kidney Ultrasound. Biopsy and CT scan lead the tests segment in the Kidney Cancer Diagnostics and Therapeutics market accounting for more than 50% of the market. The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. European is the third largest market with a global share of 25%. UK is the largest market share holder for the Kidney Cancer Diagnostics and Therapeutics market in this region, followed by Germany and France.
The major companies dominating the market in this region are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.
The Europe Kidney Cancer Diagnostics and Therapeutics Market report offers wide-range of scope: Regional and country-level analysis that provides an individual perspective of European region and the aforementioned countries Know more about key areas of industry growth via detailed Segment-level analysis on basis of type and tests sector along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
